PROGERIA (HGPS) TREATMENT WORKFLOW (from Cleveland Clinic-based plan)

1. Disease-modifying therapy
   - Lonafarnib (Zokinvy):
       - Farnesyltransferase inhibitor originally developed for cancer.
       - Improves multiple aspects of progeria: vascular flexibility, bone structure, weight gain and hearing.
       - Increases average survival by about 2.5 years.

2. Rehabilitation therapies
   - Physical therapy to improve range of motion, posture, balance and hip/foot pain.
   - Occupational therapy to support skills such as eating, hygiene, self-care and handwriting.

3. Multisystem monitoring and management
   - Cardiovascular:
       * Regular blood pressure checks and echocardiograms.
       * Low-dose aspirin and statins to reduce cardiovascular risk.
   - Neurologic:
       * MRI and other imaging to monitor for stroke, headaches and seizures.
   - Ophthalmologic:
       * Regular eye exams for refractive errors, dry eyes, cataracts and light sensitivity; encourage sunglasses use.
   - Audiologic:
       * Periodic hearing tests; fit hearing aids when needed.
   - Dental:
       * Frequent dental visits to manage cavities, crowding, delayed tooth eruption and gum recession.
   - Dermatologic and musculoskeletal:
       * Monitor for skin pigment changes, bulges, hair loss, itching, tight skin and bone/joint problems.

4. Nutrition and hydration
   - Ensure adequate calories to support growth; consider supplements or feeding tube if needed.
   - Maintain good hydration to reduce risk of sudden neurologic events.

5. Long-term goals
   - Maximize comfort, functional independence and quality of life.
   - Coordinate care through experienced centers and provide family support.
